Predictors of Visual Response After Lapse in Treatment Among Patients With Neovascular Age-related Macular Degeneration.

IF 0.9 4区 医学 Q4 OPHTHALMOLOGY
Jovana Hanna, Jonathan Markle, Christopher Maatouk, Nikhil Das, Katherine E Talcott, Rishi P Singh
{"title":"Predictors of Visual Response After Lapse in Treatment Among Patients With Neovascular Age-related Macular Degeneration.","authors":"Jovana Hanna, Jonathan Markle, Christopher Maatouk, Nikhil Das, Katherine E Talcott, Rishi P Singh","doi":"10.3928/23258160-20250128-01","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>This study aimed to analyze baseline predictors of visual response in patients with neovascular age-related macular degeneration (nAMD) who have undergone lapses in treatment with anti-VEGF therapy. The mainstay treatment option for nAMD is intravitreal vascular endothelial growth factor inhibitor (anti-VEGF) therapy. Given the chronic nature of nAMD, patients who undergo lapses in treatment with these agents can have progression of their disease.</p><p><strong>Patients and methods: </strong>This retrospective, comprehensive chart review included 261 adults aged 18 years or older who were diagnosed with nAMD between January 2012 and June 2020 and had undergone at least one anti-VEGF injection prior to an unintended lapse in follow-up of 3 months or greater. Following exclusion criteria, in which individuals were not administered an anti-VEGF injection at the pre-lapse visit, a total of 163 patients were analyzed. Patients were separated into \"vision loss\" and \"stable vision\" categories and classified based on degree of vision loss. A stepwise backward logistic regression was used to analyze baseline medical and ophthalmic factors between each group to determine which factors were more likely to be associated with more significant vision loss.</p><p><strong>Results: </strong>Out of 261 nAMD patients reviewed, 163 patients were investigated in the main analysis. Higher cube volume (1.24 ± 0.24, <i>P</i> = 0.22), and lapse length (2.89 ± 0.056, <i>P</i> = 0.004) increased the likelihood of vision loss, while lack of smoking history (-2.07 ± 0.46, <i>P</i> = 0.038) decreased the likelihood. The two groups were significantly different in post-lapse ophthalmologic continuous variables, including cube volume (9.69 ± 0.98 and 10.2 ± 1.39 in the stable vision and unstable vision groups, respectively, <i>P</i> = 0.01) and cube average thickness (269 ± 27.3 and 282 ± 38.4 in the stable vision and unstable vision groups, respectively, <i>P</i> = 0.02). The main model had an area under the curve (AUC) of 58% and predictive accuracy of 78.1%.</p><p><strong>Conclusion: </strong>The calculated AUC was not high enough to establish reliable predictability in this study. However, additional factors may need to be considered for greater predictability. <b>[<i>Ophthalmic Surg Lasers Imaging Retina</i> 2025;56:280-285.]</b>.</p>","PeriodicalId":19679,"journal":{"name":"Ophthalmic surgery, lasers & imaging retina","volume":" ","pages":"280-285"},"PeriodicalIF":0.9000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic surgery, lasers & imaging retina","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/23258160-20250128-01","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective: This study aimed to analyze baseline predictors of visual response in patients with neovascular age-related macular degeneration (nAMD) who have undergone lapses in treatment with anti-VEGF therapy. The mainstay treatment option for nAMD is intravitreal vascular endothelial growth factor inhibitor (anti-VEGF) therapy. Given the chronic nature of nAMD, patients who undergo lapses in treatment with these agents can have progression of their disease.

Patients and methods: This retrospective, comprehensive chart review included 261 adults aged 18 years or older who were diagnosed with nAMD between January 2012 and June 2020 and had undergone at least one anti-VEGF injection prior to an unintended lapse in follow-up of 3 months or greater. Following exclusion criteria, in which individuals were not administered an anti-VEGF injection at the pre-lapse visit, a total of 163 patients were analyzed. Patients were separated into "vision loss" and "stable vision" categories and classified based on degree of vision loss. A stepwise backward logistic regression was used to analyze baseline medical and ophthalmic factors between each group to determine which factors were more likely to be associated with more significant vision loss.

Results: Out of 261 nAMD patients reviewed, 163 patients were investigated in the main analysis. Higher cube volume (1.24 ± 0.24, P = 0.22), and lapse length (2.89 ± 0.056, P = 0.004) increased the likelihood of vision loss, while lack of smoking history (-2.07 ± 0.46, P = 0.038) decreased the likelihood. The two groups were significantly different in post-lapse ophthalmologic continuous variables, including cube volume (9.69 ± 0.98 and 10.2 ± 1.39 in the stable vision and unstable vision groups, respectively, P = 0.01) and cube average thickness (269 ± 27.3 and 282 ± 38.4 in the stable vision and unstable vision groups, respectively, P = 0.02). The main model had an area under the curve (AUC) of 58% and predictive accuracy of 78.1%.

Conclusion: The calculated AUC was not high enough to establish reliable predictability in this study. However, additional factors may need to be considered for greater predictability. [Ophthalmic Surg Lasers Imaging Retina 2025;56:280-285.].

新生血管性年龄相关性黄斑变性患者治疗失效后视觉反应的预测因素。
背景和目的:本研究旨在分析抗vegf治疗失败的新生血管性年龄相关性黄斑变性(nAMD)患者视觉反应的基线预测因素。nAMD的主要治疗选择是玻璃体内血管内皮生长因子抑制剂(anti-VEGF)治疗。鉴于nAMD的慢性性质,在这些药物治疗中出现失误的患者可能会出现疾病进展。患者和方法:这项回顾性的综合图表回顾包括261名18岁或以上的成年人,他们在2012年1月至2020年6月期间被诊断为nAMD,并且在随访3个月或更长时间的意外中断之前至少接受过一次抗vegf注射。根据排除标准,即患者在失效前访问时未给予抗vegf注射,共分析163例患者。将患者分为“视力丧失”和“视力稳定”两类,根据视力丧失程度进行分类。采用逐步后向logistic回归分析各组之间的基线医学和眼科因素,以确定哪些因素更可能与更严重的视力丧失相关。结果:在261例nAMD患者中,163例患者被纳入主要分析。高立方体体积(1.24±0.24,P = 0.22)和视距长度(2.89±0.056,P = 0.004)增加视力丧失的可能性,无吸烟史(-2.07±0.46,P = 0.038)降低视力丧失的可能性。两组在视力稳定组和视力不稳定组的眼立方体积(分别为9.69±0.98和10.2±1.39,P = 0.01)和眼立方平均厚度(分别为269±27.3和282±38.4,P = 0.02)上存在显著差异。主模型的曲线下面积(AUC)为58%,预测准确率为78.1%。结论:本研究计算的AUC不够高,无法建立可靠的预测。然而,为了获得更大的可预测性,可能需要考虑其他因素。[眼科外科激光成像视网膜2025;56:XX-XX]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
89
期刊介绍: OSLI Retina focuses exclusively on retinal diseases, surgery and pharmacotherapy. OSLI Retina will offer an expedited submission to publication effort of peer-reviewed clinical science and case report articles. The front of the journal offers practical clinical and practice management features and columns specific to retina specialists. In sum, readers will find important peer-reviewed retina articles and the latest findings in techniques and science, as well as informative business and practice management features in one journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信